MUGE PARK: Open Payments
NPI 1891268322 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,086 in 216 payments from 17 companies in 2025. Trend: 2023 $4,198 · 2024 $3,972 · 2025 $4,086
Food & beverage: $4,086
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 69 | $1,070 |
| ABBVIE INC. | 33 | $610 |
| AstraZeneca Pharmaceuticals LP | 23 | $564 |
| UCB, Inc. | 21 | $337 |
| E.R. Squibb & Sons, L.L.C. | 12 | $298 |
| Mallinckrodt Hospital Products Inc. | 9 | $290 |
| Novartis Pharmaceuticals Corporation | 14 | $263 |
| PFIZER INC. | 10 | $145 |
| Fresenius Kabi USA, LLC | 6 | $110 |
| Radius Health, Inc. | 5 | $103 |
Products named: SAPHNELO, ENBREL, RINVOQ, KRYSTEXXA, Bimzelx, ORENCIA, ACTHAR, COSENTYX.
Industry payments across OK — which companies pay providers there.
